Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: unexplained death; Found dead at home; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB (Regulatory Authority number AT-BASGAGES-2021-03550). A 73 years old male patient received the first single dose of BNT162B2 (COMIRNATY; lot EJ6797) intramuscular, on 10Feb2021, for COVID-19 immunisation. Medical history included ongoing fundus hypertonicus, ongoing dependence on renal dialysis, ongoing kidney failure requiring dialysis, ongoing cerebral arterial occlusive disease (occlusion of the internal carotid artery, left), ongoing hypertension arterial, ischaemic cerebral infarction from Dec2012 (st.p. multiple (embolically configured) ischemic cerebral infarcts in the flow area of the left cerebral artery), ongoing vascular encephalopathy. He had numerous unspecified multiple concomitant medications. At noon on 12Feb2021 the patient was seen on dialysis since he was symptom-free. On 14Feb2021 the patient experienced unexplained death; found dead at home. It was unknown if an autopsy was done. There were no signs of infection at the time of vaccination. There was no positive test result for SARS-CoV2 and he had no SARS-CoV2 antibodies at the time of vaccination. No follow-up attempts possible. No further information expected. ; Reported Cause(s) of Death: unexplained death; Found dead at home
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166